Dr. Reddy's management to meet investors on June 9-10
Dr. Reddy's Laboratories Limited has scheduled meetings with analysts and institutional investors on June 9 and June 10, 2026, in Mumbai and Hyderabad respectively, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Dr. Reddy's Laboratories Limited has scheduled a series of meetings with analysts and institutional investors on June 9 and June 10, 2026. The company's management will engage with single institutions and investor groups to discuss business performance and strategy. These interactions are part of the company's regular investor relations activities under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The first meeting is organized by ICICI Securities and will take place in Mumbai on June 9, 2026. This will be an in-person group meet scheduled between 10:00 and 17:00 IST. The second engagement is with Macquarie, set to occur in Hyderabad on June 10, 2026. This session is also an in-person group meet, planned for 12:00 to 13:00 IST.
| Date | Organized by | Location | Meeting mode | Nature of meet | Timing |
|---|---|---|---|---|---|
| 09.06.2026 | ICICI Securities | Mumbai | In-Person | Group Meet | 10:00 - 17:00 IST |
| 10.06.2026 | Macquarie | Hyderabad | In-Person | Group Meet | 12:00 - 13:00 IST |
The company noted that the schedule for these meetings is subject to change due to any exigencies on the part of the investors or the company. The intimation was signed by K Randhir Singh, Company Secretary, Compliance Officer & Head-CSR.
Historical Stock Returns for Dr Reddys Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.20% | -2.14% | +0.35% | +0.03% | -1.16% | +22.20% |
What strategic priorities is Dr. Reddy's likely to emphasize during these investor meetings?
How might the outcomes of these meetings influence Dr. Reddy's stock performance in the near term?
Could these discussions signal any upcoming changes in the company's business or expansion plans?


































